U87MG and U118MG glioblastoma cells exhibit high protein expression of cannabinoid receptors, CB1 and CB2 (Figure 11A, 11C) and a well pronounced dose-dependent apoptotic response to CBD treatment. This evidence concerns the gene CNR1 and glioblastoma.